Osteoporosis Flashcards

1
Q

Calcium in the bone is

A

hydroxyapatite [Ca10(PO4)6(OH)2]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Osteoblasts

A

bone forming cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Osteoclasts

A

bone resorption cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Factors released by osteocytes that stimulates osteoblasts

A

prostaglandins, NO, dentin matrix protein-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Factors released by osteocytes that stimulates osteoclasts

A

sclerostin; osteocalcin; MEPE (matrix extracellular phosphoglycoprotein)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does parathyroid hormone (PTH) do?

A
  1. increased calcium reabsorption from CT
  2. increased calcium resorption from bone
  3. increased PO4 loss in urine
  4. increased 1,25(OH)2D3 production by kidney
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PTH secretion is triggered by

A

low serum Ca2+ levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

First step of vitamin D synthesis

A

7-dehydrocholesterol -> (UV) -> cholecalciferol (D3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cholecalciferol can be obtained

A

in the diet or via exposure to sun light

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Under which conditions is 25-hydyoxyvitamin D3 converted into 1,25 Dihydroxy vit D3 (calcitriol)?

A

low phosphorus and Ca2+

PTH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Under which conditions is 25-hydyoxyvitamin D3 converted into 24,25 Dihydroxy Vit D3 (secalciferol)?

A

normal phosphorus and calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What reaction does 1-alpha-hydroxylase catalyze?

A

25-hydyoxyvitamin D3 -> 1,25 Dihydroxy vit D3 (calcitriol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What reaction does 24-hydroxylase catalyze?

A

25-hydyoxyvitamin D3 -> 24,25 Dihydroxy Vit D3 (secalciferol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Actions of vitamin D

A
  1. increased calcium and PO4 absorption from small intestine
  2. increased calcium and PO4 reabsorption
  3. indirect (slow) effects on cells
  4. feedback inhibition of PTH (1,25(OH)2D
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is upregulated by Vitamin D3?

A
  1. TrpV6
  2. Calbindin-D9k
  3. Ca2+-ATPase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which cells secrete calcitonin?

A

cells in the thyroid gland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What does calcitonin do?

A

negative regulator of serum calcium;

  1. inhibits osteoclastic bone resorption
  2. increases calcium and PO4 loss in the urine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is calcitonin stimulated by?

A

high serum calcium levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe postmenopausal osteoporosis.

A

decrease in estrogen levels causes a decrease in bone mass; shift in bone remodeling balance toward resorption; spontaneous or minimal trauma fractures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe osteoporosis related to aging.

A

caused by age-related decrease in osteoblast activity in both men and women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Vertebral complications of osteoporosis

A

fragility fractures; pain; height loss; kyphosis; activity limitations; restrictive lung disease; psychological symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Risk factors for osteoporosis

A

Physical inactivity; age; low calcium intake in early years; long-term glucocorticoid therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Hyperparathyroidism

A

increased bone resorption and decreased calcium excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Hypercalcemia caused by malignant tumors

A

some tumors produce a peptide with PTH activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

CNS complications from hypercalcemia

A

depression and coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Hypocalcemia can be caused by

A

hypoparathyroidism or vit. D deficiencies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Symptoms of hypocalcemia

A

causes neuromuscular disturbances, parasthesias, tetany, and muscle cramps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Rickets

A

Vitamin D deficieny; weight bearing bone deformities in children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Vitamin D preparations

A

Cholecalciferol Vit D3 (OTC)
Calcifediol 25(OH)Vit D3 (Calderol)
Calcitriol 1,25(OH)2VitD3 (Rocaltrol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

MOA of Vitamin D supplements

A

increased calcium and PO4 absorption from gut

increased calcium and PO4 reabsorption in renal tubules

31
Q

Pagets disease

A

uncontrolled osteoclastic bone resorption and secondary bone formation

32
Q

Symptoms of Pagets disease

A
  1. bone pain
  2. bone deformities
  3. loss of hearing, hypercalcemia
  4. may be caused by a slowly acting virus
33
Q

How do loop diuretics affect serum Ca2+ levels?

A

increased calcium excretion

decreased driving force for uptake with inhibition of Na+/K+/2Cl- co-transporter

34
Q

How do thiazides affect serum Ca2+ levels?

A

decreased calcium excretion

increased driving force for uptake with inhibition of Na/Cl transporter in the distal tubule

35
Q

How do PPIs and H2 antagonists affect serum Ca2+ levels?

A

decreased acidity of stomach decreases calcium absorption (Omeprazole may inhibit bone resorption)

36
Q

How do carbemazepine, isoniazid, theophylline and rifampin affect Ca2+ levels?

A

induction of Vit. D catabolic P450s

37
Q

First line therapy for osteoporosis

A

Bisphosphonates

38
Q

Bisphosphonates are analogs of what?

A

analogs of inorganic pyrophosphate

39
Q

MOA of bisphosphonates

A

reduce formation and dissolution of hydroxyapatite crystals by accumulating in bone as part of the matrix; disrupt cytoskeleton, induce apoptosis, inhibit farnesyl-PP synthesis of osteoclasts

40
Q

Adverse effects of bisphosphonates

A

NVD, musculoskeletal pain, osteonecrosis of the jaw, atypical femur fractures

41
Q

What do bisphosphates do?

A

reduce formation and dissolution of hydroxyapatite crystals by accumulating in bone as part of the matrix; disrupt cytoskeleton, induce apoptosis, inhibit farnesyl-PP synthesis of osteoclasts

42
Q

Bisphosphonates approved for osteoporosis (builds bone mass)

A

Zoledronate (Reclast)
Alendronate (Fosamax)
Risedronate (Actonel)
Ibandronate (Boniva)

43
Q

MOA of bisphosphates

A

inhibition of farnesyl pyrophosphate synthase; disrupts prenylation of proteins in osteoclasts

44
Q

Second line treatment for osteoporosis

A

Estrogens and SERMs
Calcitonin
Teriparatide (Forteo)

45
Q

What do Estrogens and SERMs do?

A
  1. prevention and control of postmenopausal bone resorption

2. increases activity of osteoblasts, decreases activity of osteoclasts

46
Q

Risks with Raloxifene

A

less cancer risk than estrogen, but risk for VTE and death from stroke

47
Q

Estrogens and SERMs used 2nd line for osteoporosis

A

Estradiol and Raloxifene

48
Q

Calcitonin formulations

A

Calcimar and Miacalcin (salmon)

Cibacalcin (human)

49
Q

What does calcitonin treatment do?

A

decreased osteoclast activity, blocks renal reabsorption of PO4 and calcium

50
Q

Clinical uses of calcitonin

A

Paget’s disease;
hypercalcemia secondary to malignancy;
Osteoporosis

51
Q

Side effects of calcitonin

A

urticaria, hand swelling, nausea

52
Q

What is Teriparatide (Forteo)?

A

amino acids 1-34 of parathyroid hormone produced in E. coli

53
Q

What does Teriparatide do?

A

preferentially stimulates osteoblast activity

54
Q

Clinical uses of Teriparatide

A

for treatment of osteoporosis in patients with a high risk of fracture

55
Q

AEs of Teriparatide

A

orthostatic hypotension, hypercalcemia, arthralgias, allergic reactions

56
Q

What does intermittent dosing of Teriparatide result in?

A

increased osteoblast number/function -> increased bone formation -> increased bone mass/strength

57
Q

What does continuous dosing of Teriparatide result in?

A

increased osteoclast activity; increased bone resorption; increased serum calcium

58
Q

Pros of Teriparatide compared to bisphosphonates

A

may be more effective in preventing fractures than bisphosphates; builds bone mass at a higher rate than bisphosphates; may allow better bone healing after fracture than bisphosphonates

59
Q

Cons of Teriparatide compated to bisphosphonates

A

must be injected daily; not recommended beyond 2 years; black box warning required by FDA for risk of bone cancer

60
Q

Denosumab (Prolia, Xgeva)

A

humanized monoclonal Ab against RANKL

61
Q

MOA of Denosumab

A

binds to RANKL and prevents activation of RANK on osteoclast precursors, preventing differentiation of osteoclasts

62
Q

Clinical use of Denosumab

A

for treatment of osteoporosis in postmenopausal women with a history of fractures, high risk of fractures or intolerance to bisphosphonates

63
Q

What must Denosumab be taken with?

A

patients must take 1000 mg calcium and 400 IU Vit D daily

64
Q

AEs of Denosumab

A

hypocalcemia, osteonecrosis of the jaw, atypical femur fractures, musculoskeletal pain, severe infections, skin reactions

65
Q

Clinical use of Cinacalcet (Sensipar)

A

Primary hyperparthyroidism;
Parathyroid carcinoma;
Secondary HPT in CKD with dialysis

66
Q

MOA of Cinacalcet (Sensipar)

A

binds to calcium-sensing receptor (a GPCR on PTH gland to inhibit release of PTH); allosteric regulator - causes receptor to be more sensitive to calcium

67
Q

Cinacalcet (Sensipar) decreases

A

both serum PTH levels and serum calcium levels

68
Q

Risks with Cinacalcet (Sensipar)

A

risk of hypocalcemia, seizures, adynamic bone disease

69
Q

Analogs of Vitamin D

A

Zemplar and Hectorol

70
Q

Calcific uremic arteriolopathy

A

Calcium can combine with (PO4)3- and precipitate in tissues - calcification

71
Q

Phosphate binders

A

complex with dietary phosphate and prevent absorption from GI

72
Q

Lanthanum Carbonate (Fosrenol)

A

forms insoluble LaPO4 salts in the GI tract; decreases serum (PO4)3- and calcium levels

73
Q

Sevelamer (Renagel, Renvela)

A

Amine-containing polymer that binds (PO4)3- in the GI tract; decreases serum (PO4)3- levels selectively